Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis
المؤلفون الرئيسيون: | Anthony, D, Sibson, N, Losey, P, Piani, D, Leppert, D |
---|---|
التنسيق: | Conference item |
منشور في: |
2009
|
مواد مشابهة
-
The antineoplastic properties of FTY720: Evidence for the repurposing of fingolimod
حسب: Patmanathan, S.N., وآخرون
منشور في: (2015) -
Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.
حسب: Anthony, D, وآخرون
منشور في: (2014) -
The Immunosuppressant FTY720 (Fingolimod) enhances Glycosaminoglycan depletion in articular cartilage
حسب: Stradner Martin H, وآخرون
منشور في: (2011-12-01) -
Ameliorative effects of Fingolimod (FTY720) on microglial activation and psychosis-related behavior in short term cuprizone exposed mice
حسب: Siyao Li, وآخرون
منشور في: (2023-07-01) -
The Immunosuppressant Fingolimod (FTY720) for the Treatment of Mechanical Force-Induced Abnormal Scars
حسب: Masayo Aoki, وآخرون
منشور في: (2020-01-01)